Search results for "Juva"

showing 10 items of 739 documents

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pne…

2007

Annual circulation of influenza virus coincides with a peak in cardiovascular and pneumonia mortality/morbidity. This study aimed to determine the effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisation due to acute coronary syndrome (ACS), cerebrovascular accident (CVA) and pneumonia in the elderly. Three case-control studies were performed during the 2004-2005 influenza season in three health districts in Valencia, Spain (total elderly [>64 years of age] population: n=105,454). Controls were patients admitted for an acute surgical process or trauma within 10 days of case admission. In total, 159 patients were hospitalised for ACS, 148 for CVA and 242 for p…

Relative risk reductionSqualeneAcute coronary syndromemedicine.medical_specialtyInfluenza vaccinePopulationPolysorbatesMass VaccinationAdjuvants ImmunologicRisk FactorsInternal medicinemedicineHumanseducationAgedAged 80 and overeducation.field_of_studyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryRespiratory diseasePublic Health Environmental and Occupational HealthOdds ratioPneumoniamedicine.diseaseVaccinationHospitalizationPneumoniaCerebrovascular DisordersInfectious DiseasesCardiovascular DiseasesInfluenza VaccinesSpainCase-Control StudiesImmunologyVaccines SubunitMolecular MedicinebusinessVaccine
researchProduct

Early rehabilitation of cancer patients - a randomized controlled intervention study.

2013

Published version of an article in the journal: BMC Cancer. Also available from the publisher at: http://dx.doi.org/10.1186/1471-2407-13-9 Open access Background: Faced with a life-threatening illness, such as cancer, many patients develop stress symptoms, i.e. avoidance behaviour, intrusive thoughts and worry. Stress management interventions have proven to be effective; however, they are mostly performed in group settings and it is commonly breast cancer patients who are studied. We hereby present the design of a randomized controlled trial (RCT) evaluating the effectiveness and cost-effectiveness of an individual stress-management intervention with a stepped-care approach in several cance…

Research designCounselingMaleCancer ResearchMedicin och hälsovetenskapTime Factorsmedicine.medical_treatmentCost-Benefit AnalysisAnxietyVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Onkologi: 762Medical and Health Scienceslaw.inventionStress Disorders Post-TraumaticStudy ProtocolRandomized controlled trialCost of IllnesslawNeoplasmsSurveys and QuestionnairesActivities of Daily LivingAdaptation PsychologicalLongitudinal StudiesProspective StudiesHospital CostsIndividual stress managementProspective cohort studyFatiguemedia_commonDepressionAdjuvant/curative therapyVDP::Medical disciplines: 700::Health sciences: 800lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMental HealthTreatment OutcomeOncologyResearch DesignVDP::Midical sciences: 700::Clinical medical sciences: 750::Oncology: 762FemaleWorryMental Health ServicesSleep Wake Disordersmedicine.medical_specialtyImpact of event scalePsychometricsmedia_common.quotation_subjectMotor Activitylcsh:RC254-282Breast cancerIntervention (counseling)GeneticsmedicineHumansRCT with stepped-care approachMotivationCognitive Behavioral Therapybusiness.industryPhysical activityCancermedicine.diseasePhysical therapyCognitive therapyQuality of LifebusinessSleepStress PsychologicalBMC cancer
researchProduct

NEONAX trial: Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer, a phase II study of the AI…

2019

4128 Background: Survival in pancreatic cancer (PDAC) is still poor even after curatively intended resection. Perioperative treatment approaches improve outcome in various tumor entities. Data on perioperative treatment in resectable PDAC are limited and there is a debate whether neoadjuvant treatment might impair subsequent surgery by adding perioperative morbidity or mortality. Methods: NEONAX is a randomized phase II study (planned 166 patients) of perioperative gemcitabine/nab-paclitaxel (Arm A: 2 pre- and 4 post-operative cycles, Arm B: 6 cycles adjuvant) for patients with primarily resectable PDAC. Primary objective is DFS at 18 months after randomization. Secondary objectives are 3-…

Resectable Pancreatic CancerOncologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentPhases of clinical researchPerioperativeInterim analysismedicine.diseaseGemcitabine3. Good health03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisInternal medicinePancreatic cancermedicinebusinessAdjuvant030215 immunologymedicine.drugNab-paclitaxelJournal of Clinical Oncology
researchProduct

Preclinical Retinal Neurodegeneration in a Model of Multiple Sclerosis

2012

Neurodegeneration plays a major role in multiple sclerosis (MS), in which it is thought to be the main determinant of permanent disability. However, the relationship between the immune response and the onset of neurodegeneration is still a matter of debate. Moreover, recent findings in MS patients raised the question of whether primary neurodegenerative changes can occur in the retina independent of optic nerve inflammation. Using a rat model of MS that frequently leads to optic neuritis, we have investigated the interconnection between neurodegenerative and inflammatory changes in the retina and the optic nerves with special focus on preclinical disease stages. We report that, before manif…

Retinal Ganglion CellsPathologyTime FactorsStilbamidinesgenetic structuresJournal ClubFreund's Adjuvantchemistry.chemical_compoundBlood-Retinal BarrierStudent’s SectionCell DeathMicrogliabiologyGeneral NeuroscienceRetinal DegenerationNeurodegenerationArticlesmedicine.anatomical_structureSpinal CordRetinal ganglion cellOptic nerveFemaleMicrogliaMyelin Proteinsmedicine.medical_specialtyMultiple SclerosisEnzyme-Linked Immunosorbent AssayRetinaMyelin oligodendrocyte glycoproteinMicroscopy Electron TransmissionAntigens CDOccludinGlial Fibrillary Acidic ProteinIn Situ Nick-End LabelingmedicineAnimalsOptic neuritisAquaporin 4Retinabusiness.industryMacrophagesMultiple sclerosisMembrane ProteinsRetinalOptic Nervemedicine.diseaseeye diseasesRatsDisease Models Animalchemistrybiology.proteinMyelin-Oligodendrocyte Glycoproteinsense organsbusinessNeuroscienceThe Journal of Neuroscience
researchProduct

Quantification of Radiation Biomarkers in Leukocytes of Breast Cancer Patients Treated with Different Modalities of 3D-CRT or IMRT

2016

The goal of this study was to determine whether the quantification of radiation biomarkers in peripheral leukocytes of 111 breast cancer patients after adjuvant treatment with different modalities of three-dimensional conformal radiation therapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) revealed any difference in the patients' radiation burden by out-of-field doses and an associated risk of second malignancies. Whole-breast radiation therapy was performed by 3D-CRT using either a hard wedge (n = 32) or a virtual wedge (n = 49) at dose rates of 3 and 6 Gy per min each. Patients receiving additional radiotherapy to lymph nodes were treated by 3D-CRT (n = 21) or IMRT (n = 9). DN…

Riskmedicine.medical_treatmentBiophysicsBreast Neoplasms030218 nuclear medicine & medical imagingHistones03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineRadiation sensitivityBreast cancerLeukocytesmedicineHumansRadiology Nuclear Medicine and imagingChromosome AberrationsRadiationbusiness.industryDose-Response Relationship Radiationmedicine.diseasePeripheralRadiation therapy030220 oncology & carcinogenesisFemaleRadiotherapy Intensity-ModulatedLymphbusinessNuclear medicineAdjuvantBiomarkersEx vivoRadiation Research
researchProduct

B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2/6-VLP spe…

2015

The purpose of this study was to evaluate the adjuvant effect of the B subunits of cholera toxin (CT) and the thermolabile enterotoxin of Escherichia coli (LT) by the intrarectal route of immunization and compare them to the whole molecules CT and LT-R192G, a non toxic mutant of LT, using 2/6-VLP as an antigen, in mice. All molecules induced similar antigen specific antibody titers in serum and feces, whereas different T cell profiles were observed. CTB and LTB, conversely to CT and LT-R192G, did not induce detectable production of IL-2 by antigen specific T cells. Moreover, CTB, conversely to LT-R192G, CT and LTB, did not induce antigen specific CD4+CD25+Foxp3- and Foxp3+ T cells, thus sho…

RotavirusCholera Toxin[SDV]Life Sciences [q-bio]T cellmedicine.medical_treatmentBacterial ToxinsEnterotoxinBiologymedicine.disease_causeAntibodies ViralMicrobiologyAntibodiesMicrobiologyB subunitEnterotoxinsFecesMiceAntigenAdjuvants ImmunologicImmunologicAdministration RectalmedicineAnimalsViralAdjuvantsIL-2 receptorVaccines Virus-Like ParticleThermolabileB cellVaccinesIntrarectalEscherichia coli ProteinsCholera toxinRotavirus VaccinesLT-R192G3. Good healthVirus-Like ParticleInfectious Diseasesmedicine.anatomical_structureAdministrationAntibody FormationInterleukin-2Th17 CellsImmunizationRectalAdjuvantImmunologic MemoryMicrobial pathogenesis
researchProduct

Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and wit…

2013

International audience; In this study, we compared both the profile and distribution of antigen specific primed T cells after intrarectal (IR) and intranasal (IN) immunization with rotavirus (RV) 2/6-VLP, alone or in the presence of LT-R192G, in order to highlight the differences between the two routes and the impact of the adjuvant. Adult BALB/c mice were immunized once with 2/6-VLP with or without adjuvant and the T cell response was analyzed in lymphoid tissues after in vitro restimulation with the antigen. IN, but not IR, immunization of mice with 2/6-VLP alone induced antigen-specific IL-10 and IL-17 secreting T cells. IL-10-, in contrast to IL-17-, secreting T cells did not migrate to…

Rotavirusmedicine.medical_treatmentT-Lymphocytes[SDV]Life Sciences [q-bio]Priming (immunology)DistributionPHENOTYPEPROTECTSEnterotoxins0302 clinical medicineCell MovementINFECTIONMesenteric lymph nodesHEAT-LABILE TOXINIMMUNE-RESPONSEIL-2 receptorAntigens Viral0303 health sciencesB-LymphocytesMice Inbred BALB CIntrarectalEscherichia coli ProteinsVaccinationFOXP3CHOLERA-TOXINLT-R192G3. Good healthInfectious Diseasesmedicine.anatomical_structureIntranasal030220 oncology & carcinogenesisMolecular MedicineFemaleAdjuvantLymphoid TissueT cellBacterial ToxinsSpleenBiologyMUCOSAL VACCINESRotavirus Infections03 medical and health sciencesCross-PrimingAntigenAdjuvants ImmunologicAdministration RectalVIRUS-LIKE PARTICLESmedicineAnimalsVaccines Virus-Like ParticleImmunity MucosalAdministration Intranasal030304 developmental biologyGeneral VeterinaryGeneral Immunology and MicrobiologyInterleukinsPublic Health Environmental and Occupational HealthRotavirus VaccinesT cellMICEImmunologyCHALLENGE
researchProduct

Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations : Results from a Multi-institutional European Retrospective Study

2022

[Purpose] The effect of high-dose imatinib (800 mg/day) on survival in the adjuvant treatment of patients with resected KIT exon 9–mutated gastrointestinal stromal tumors (GIST) is not established. Here, the association of dose and other clinicopathologic variables with survival was evaluated in a large multi-institutional European cohort.

STRUCTURAL BASISEXPRESSIONOncologyCancer Researchmedicine.medical_specialtyGastrointestinal Stromal Tumors3122 CancersMedizinAntineoplastic Agentsexon 9Adjuvants ImmunologicInternal medicinemedicineHumansFAILURERetrospective StudiesRISKRECEPTORGiSTProportional hazards modelbusiness.industryGASTROINTESTINAL STROMAL TUMORSHazard ratioImatinibRetrospective cohort studyExonsAdjuvant treatmentConfidence intervalGENOTYPEProto-Oncogene Proteins c-kitOncologyChemotherapy AdjuvantMutationPropensity score matchingCohortImatinib MesylateNeoplasm Recurrence LocalTYROSINE KINASE INHIBITORbusinessRare cancers Radboud Institute for Health Sciences [Radboudumc 9]medicine.drugGIST
researchProduct

Dalla “Sé-cattedrale” al “Sé-Nazione”. Sull’architettura della città e del territorio lusitano: chiavi di lettura storico-antropologiche

2010

La città è traccia architettonico-morfologica della storia che la produce. In pochi paesi l’urbe ha tracciata in sé, così chiaramente, l’evoluzione di questa storia, come in Portogallo, fra i più antichi per unità nazionale. L’articolo propone un percorso attraverso la formazione identitaria portoghese, dalla crescita economica, fasi coloniali, sino alla decadenza dell’economia marittima. Economia, questa, che anche attraverso l’urbe, come luogo privilegiato di sviluppo, decreta il vero inizio della globalizzazione planetaria. L’excursus storico si conclude con la crisi identitaria di fine Ottocento, per tracciare quello che è il profilo dell’immaginario nazionale portoghese, soprattutto co…

SaramagocittàPortogalloSettore ICAR/14 - Composizione Architettonica E UrbanaPortostoriaArchitetturaJuvarraSé-nazioneterritorio semanticoTerritorialità politicaunità linguistico-tipologicaCamõeNicolau Nasoni
researchProduct

Ne sous-estimons pas le risque à long terme de second cancer pulmonaire après exérèse chirurgicale d'un cancer du poumon non à petites cellules

2019

Etat de la question Plusieurs etudes ont montre que les survivants d’un cancer du poumon sont a haut risque de developper un second cancer broncho-pulmonaire (SCBP). L’evaluation du risque de SPBC au cours du temps a d’importante repercussion sur la strategie de surveillance post-chirurgicale des cancers du poumon non a petites cellules (CPNPC). L’objectif principal de cette etude etait de mesurer le risque de SCP sur le long terme en tenant compte du risque competitif de deces. Materiel et methodes Le risque cumule de SCBP a ete estime a l’aide de l’incidence cumulee chez des patients operes en resection complete d’un CPNPC de stade I a III diagnostiques entre 2002 et 2015 et recenses par …

Second cancer broncho-pulmonaireEpidemiologyPublic Health Environmental and Occupational HealthRadiothérapie adjuvantesuivi[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieEnquête en populationCancer du poumon non à petites-cellulesComputingMilieux_MISCELLANEOUSRisque compétitifs3. Good health
researchProduct